Comment on

• Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group.

  Menache D, O'Malley JP, Schorr JB, Wagner B, Williams C, Alving BM, Ballard JO, Goodnight SH, Hathaway WE, Hultin MB, et al. Menache D, et al. Blood. 1990 Jan 1;75(1):33-9. Blood. 1990. PMID: 2403821